BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk

See teave on mõeldud ainult uurimis- ja hariduslikel eesmärkidel. Ei ole meditsiiniline soovitus. Tooted ei ole heaks kiidetud kasutamiseks inimestel. Terviseküsimustes pöördu arsti poole.

Leksikon

Tretinoin (Retin-A)

The acid form of vitamin A for the skin: the longest-studied topical retinoid in acne and sun-induced skin aging research.

7 min read 7 sources

Elongated molecule model of blue glass spheres with a ring at one end above a white podium with a glowing light blue rim in a bright lab
Compound approved · since 1971

Summary

At a glance

Sources checked on 26 Oct 2026

Faces with visible improvement
93 %

14 of 15 after 16 weeks, none on the inactive cream1

Absorption through the skin
~2 %

after more than a year of daily use 1.1 percent, blood levels unchanged5

Fewer collagen-degrading enzymes
~70 %

70 to 80 percent less rise after UV exposure when applied beforehand4

Longest placebo study
2 years

204 participants, wrinkles and spots better, no abnormal cells3

  • Tretinoin is all-trans retinoic acid, the active acid form of vitamin A. It binds to retinoic acid receptors in the cell nucleus and changes which genes are active in the skin.7
  • In the first study on photoaging 14 of 15 treated faces improved after 16 weeks, none on the inactive cream.1
  • The higher and the lower concentration worked equally well over 48 weeks, but the higher one irritated clearly more often. Over two years wrinkles and pigment spots kept improving.23
  • Applied before UV light tretinoin slowed the enzymes that break down collagen by 70 to 80 percent. Only about 2 percent reaches the blood.45
  • According to ChEMBL tretinoin has been approved since 1971. Everything here is the state of research, not a recommendation.7
Profiil

Updated October 2026

Class
Retinoid

all-trans retinoic acid, topical

Use
Cream on the skin

once nightly, pea-sized amount

Systemic uptake
About 2 percent

plasma levels stay in the normal range

Onset
Acne 8 to 12 weeks

photoaging 4 to 6 months

Status
Prescription drug

reference compound in photoaging

Form
20 g tube

0.05% and 0.1%

Sizes
2 sizes

0.05%*20g, 0.025%*20g

Sisu 13 sections
  1. Lühidalt
  2. What is tretinoin?
  3. How it works
  4. Use and dosing
  5. What the research shows
  6. Uuringute seis
  7. Tretinoin versus isotretinoin
  8. Side effects
  9. Storage
  10. Seotud ühendid
  11. KKK
  12. Mõisted
  13. Allikad

What is tretinoin?

Tretinoin is all-trans retinoic acid, the biologically active acid form of vitamin A. Your body makes small amounts of it from retinol; as a cream it goes straight onto the skin. It is the sister molecule of isotretinoin (13-cis retinoic acid), which is taken by mouth, but applied as a cream its effect stays where you put it.

It came out of acne research in the 1960s and has been available as a cream since the 1970s. In the 1980s dermatologists noticed that fine lines and pigment spots were changing under the acne cream as well. Tretinoin became the reference compound against which every new agent for photoaged skin is measured.

The catalogue lists tretinoin as a cream in a 20 g tube at 0.05% and 0.1%. Both strengths sit inside the range the trials used, which runs from 0.025% to 0.1%.

This information is for research and educational purposes only. No medical advice.

How it works

Once inside the skin cell, tretinoin binds to retinoic acid receptors (RAR) in the nucleus, mostly the gamma subtype in skin. The receptor then switches genes on and off. In the epidermis that means faster keratinocyte turnover, a thinner and more even stratum corneum and loosening of the keratin plugs that block sebaceous follicles. This is why comedones recede in the trials and fewer new ones form.

In the dermis a second mechanism runs. UV light activates the transcription factor AP-1, which drives matrix metalloproteinases, the enzymes that break down collagen. Tretinoin suppresses AP-1 and with it those enzymes. Fisher and colleagues showed this in irradiated human skin in the New England Journal of Medicine in 1997: pretreatment with tretinoin cut the enzyme induction by 70 to 80 percent. At the same time procollagen synthesis rises; in the two-year trial by Kang and colleagues the procollagen marker was significantly higher at month 12.

Almost none of it reaches the bloodstream. Latriano and colleagues measured about 2 percent percutaneous absorption after a single dose of radiolabelled tretinoin and 1.1 percent after more than a year of daily use, with plasma levels of tretinoin and its metabolites staying within the endogenous range. The action is local, which is why the side effect profile has little in common with oral isotretinoin.

Where it acts

Where tretinoin acts

Tap a point or a card. Colour = retinoic acid receptor, grey = observed in studies.

  1. Skin

    Epidermis about 30% thicker, fewer collagen-degrading enzymes after UV2

    RAR
  2. Blood

    About 2% gets in, the body's own levels stay the same5

    Observed in trials

Targets in the ChEMBL database7

Compound CHEMBL38: one recorded mechanism, Agonist of the RAR family according to ChEMBL.

Retinoic acid receptor gamma
Gene
RARG
UniProt
P13631
ChEMBL
CHEMBL2003
Action
Agonist of the RAR family according to ChEMBL
Glass skin layers, two blue molecules above them sending beams of light into the cell nuclei of the top layer
Tretinoin acts via receptors in the cell nucleus of the skin. Symbolic image.

Use and dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts
Plain white tube without print next to a small glass dish with a pea-sized dab of white cream
Cream for applying to the skin. Symbolic image.

What the research shows

Weiss and colleagues (JAMA 1988) made tretinoin known beyond acne. Thirty participants applied tretinoin to one forearm and the drug-free vehicle to the other for 16 weeks; half also applied tretinoin to the face. Every tretinoin forearm improved measurably, no vehicle forearm did. Fourteen of the 15 tretinoin faces improved, none of the vehicle faces. Under the microscope the changes were significant, but only in tretinoin-exposed skin.

Griffiths and colleagues (Archives of Dermatology 1995) settled the strength question: 99 participants, 0.1% and 0.025% cream against vehicle, double-blind, 48 weeks. Both strengths improved photoaging to the same degree and thickened the epidermis by about 30 percent, but 0.1% irritated the skin significantly more often. That is the single most useful data point for choosing a concentration.

Kang and colleagues (American Journal of Clinical Dermatology 2005) ran the longest placebo-controlled trial: 204 participants with moderate to severe facial photodamage applied 0.05% emollient cream or placebo for two years. Fine and coarse wrinkling, mottled pigmentation and sallowness improved significantly against placebo. Biopsies showed no increase in atypical cells and no damage to the stratum corneum, but a significant rise in the procollagen marker at month 12.

Fisher and colleagues (NEJM 1997) supplied the mechanism in 59 volunteers: a single UV exposure raised three collagen-degrading enzymes and increased collagen breakdown by 58 percent, while tretinoin applied beforehand blocked 70 to 80 percent of the enzyme induction. Latriano and colleagues (JAAD 1997) supplied the pharmacokinetics: roughly 2 percent absorption through the skin after a single dose and after 28 days, only 1.1 percent in participants with more than a year of use. Endogenous plasma levels did not change.

For acne the evidence base is even broader. Topical retinoids are a cornerstone of the American and European acne guidelines. Tretinoin is the oldest member of the group. For hair growth the data are thin: a small 1986 study tested tretinoin alone and together with minoxidil. Little has followed since.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

Faces with improved photoaging1

15 participants each, double-blind, inactive cream as comparison

Face1 14 of 15 versus 0 of 15
Inactive cream 0%
Tretinoin 93%

In addition all 30 participants applied tretinoin to one forearm and the inactive cream to the other. All tretinoin arms improved, no comparison arm did. The only side effect was irritation of the treated skin.

Changes in the skin2

99 participants with photoaging, double-blind, tissue samples

Epidermal thickness2
Inactive cream -11%
Lower concentration +28%
Higher concentration +30%
Blood supply (vessel area)2
Inactive cream -9%
Lower concentration +89%
Higher concentration +100%

Clinically both concentrations improved photoaging equally. Redness and scaling were significantly more frequent with the higher concentration. The authors conclude that irritation is not the reason for the effect.

Collagen breakdown after UV light4

Healthy volunteers, irradiated versus non-irradiated skin

Collagen breakdown after one exposure4
UV light without tretinoin +58%
Rise of degrading enzymes with tretinoin beforehand4 70 to 80 percent inhibited
Tretinoin -70%

Tretinoin was applied 48 hours before irradiation. It did not change the body's own inhibitor of the enzymes.

Cross-section skin model with visible layers on a glass stand, a green plant beside it in front of a window
The studies measured wrinkles, pigment and tissue samples. Symbolic image.

Research status

Where the research stands

Tretinoin has been approved since 1971. On ClinicalTrials.gov 406 trials name tretinoin, 65 of them on acne or photoaging. The large photoaging studies ran before the registry. Shown is a selection of later skin trials. As of 26 Oct 2026. 6

  1. Preclinical Principle: retinoic acid receptors in the cell nucleus, inhibition of collagen-degrading enzymes
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 3 trials, 3 completed
  5. Approval since 1971
1,532 participants in phase 3 Approved: ChEMBL lists tretinoin with phase 4 as the highest phase, first approval in 1971 and use on the skin.7
Show all 6 phase 3 and 4 trials on a timelineHide timeline 6 completed 0 running 0 with results
Phase 3
Phase 4

Bar: start to primary endpoint (planned for running trials). Green = completed, blue = progress until 26 Oct 2026.

Tretinoin versus isotretinoin

Both are retinoic acids and both descend from vitamin A. Still, they are two different tools. Tretinoin works where it is applied: in the epidermis and the upper dermis. Isotretinoin is swallowed, spreads through the whole body, shrinks the sebaceous glands and brings a strict safety profile with it, above all harm to a fetus.

That gives the division of labour in research: tretinoin for mild to moderate acne, comedones, pigment spots and photoaging, isotretinoin for severe, scarring acne. Used together on the skin the two add up dryness and irritation, which is why the literature advises against continuing topical retinoids during an isotretinoin course.

Adapalene, a synthetic third-generation retinoid, binds the receptors more selectively and is stable in light. It irritates less, but has far fewer data in photoaging than tretinoin.

Comparison

Skin compounds in the lexicon

Tretinoin next to its swallowed sister and two peptides for the skin, as stated in the TPD lexicon. Tap a card to open its entry.

Retinoic acid as cream Tretinoin (Retin-A) RAR
13-cis retinoic acid as tablet Isotretinoin Copper peptide for the skin GHK-Cu
Signal peptide for the skin Matrixyl - Peptide Topical for Skin Firmness

Simplified: tretinoin acts where it is applied. Isotretinoin is swallowed and acts throughout the body. 75

Side effects

  • Retinoid dermatitis: redness, flaking, burning, dryness and tightness, mainly in the first 2 to 4 weeks. It is the most common effect by far and the reason for the slow start. In Griffiths and colleagues, irritation was significantly more frequent at 0.1% than at 0.025% with no difference in effect. If it gets too much: skip a night, moisturise, do not increase the amount.
  • Initial acne flare: more spots can appear in the first weeks as blocked follicles empty out. It usually settles by week 6 to 8.
  • Photosensitivity: skin under tretinoin burns faster. Sunscreen is not optional, it is part of the application.
  • Pigment changes: occasionally lighter or darker patches, mostly temporary, more often in darker skin types and where the skin is irritated.
  • Pregnancy: retinoids are regarded as off limits in pregnancy. A meta-analysis in the British Journal of Dermatology (2015) found no significant rise in malformations across 654 exposed pregnancies, but stated itself that it was too small to prove safety. The rule therefore stands: not in pregnancy, not when trying to conceive.
  • Interactions on the skin: benzoyl peroxide can oxidise tretinoin; alcohol-based toners, exfoliants and scrubs amplify irritation. Avoid waxing and laser on the areas you apply tretinoin to in the days before and after.

Storage

Keep the tube tightly closed at room temperature, 15 to 25 °C, protected from light and heat. Tretinoin is sensitive to light and oxidation, so the tube does not belong on a windowsill or next to the bathroom radiator. Do not freeze. After opening, use within the period printed on the pack. Keep out of reach of children.

Related

Related compounds

A different path: all in the TPD lexicon.

FAQ

Common questions about Tretinoin (Retin-A)

Short answers, each backed by the sources below.

What is the difference from isotretinoin?

Both are retinoic acids. Tretinoin is applied as a cream and acts there, only about 2 percent reaches the blood and the body's own levels stay the same. Isotretinoin is swallowed and acts throughout the body.5

Is tretinoin approved?

Yes. ChEMBL lists tretinoin with first approval in 1971 and use on the skin. On ClinicalTrials.gov 406 trials name tretinoin (as of 26 October 2026).76

Does the higher concentration do more?

Not for photoaging. Over 48 weeks both concentrations improved the skin equally and thickened the epidermis by 30 and 28 percent. Redness and scaling were significantly more frequent with the higher concentration.2

How does tretinoin protect collagen?

UV light ramps up enzymes that break down collagen. After a single exposure collagen breakdown rose by 58 percent. When tretinoin was applied 48 hours beforehand the rise of these enzymes fell by 70 to 80 percent.4

Has long-term use been studied?

Yes, over two years in 204 participants against an inactive cream. Fine and coarse wrinkles, pigment spots and sallowness improved. Tissue samples showed no increase in abnormal cells, but more procollagen formation after 12 months.3

Which side effects are known?

Mainly irritation of the treated skin with redness and scaling, stronger at higher concentration. In the 16-week study this irritation was the only side effect. According to the entry tretinoin also makes the skin more sensitive to light.12

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

AP-1
Switch in the cell nucleus that UV light activates. It drives the collagen-degrading enzymes.
Epidermis
The outermost layer of the skin.
Keratinocytes
Main cells of the epidermis. They form the horny layer.
Matrix metalloproteinases
Enzymes that break down collagen and other building blocks of connective tissue. UV light ramps them up.
Photoaging
Skin aging caused by UV light, with wrinkles, pigment spots and loose skin.
Procollagen
Precursor of collagen. More procollagen shows that the skin is making new collagen.
Retinoic acid
Active acid form of vitamin A. The body makes small amounts itself from retinol.
Retinoic acid receptors
Receptors in the cell nucleus that switch genes on and off after binding retinoic acid.
Retinoid dermatitis
Irritation at the start with redness, scaling and burning. The most common side effect, mostly in the first weeks.
Vehicle
The same cream without the active compound, the placebo for creams.

Tõendid

Allikad

Show all 7 sourcesHide sources 3 Studies1 Trial registry3 Database checked 26 Oct 2026

Studies

  1. Two years of tretinoin cream versus placebo

    Kang et al., American Journal of Clinical Dermatology, 2005

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. UV light, collagen breakdown and tretinoin

    Fisher et al., New England Journal of Medicine, 1997

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. Absorption of tretinoin through the skin

    Latriano et al., Journal of the American Academy of Dermatology, 1997

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed

Trial registry

  1. Trials on tretinoin on ClinicalTrials.gov

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. Tretinoin in photoaging versus inactive cream, 16 weeks (PubMed record)

    Weiss et al., JAMA, 1988 (DOI 10.1001/jama.1988.03720040019020 laut Crossref)

    Checked 26 Oct 2026 via PubMed, Crossref, doi.org
  2. Two concentrations over 48 weeks (PubMed record)

    Griffiths et al., Archives of Dermatology, 1995 (DOI 10.1001/archderm.1995.01690210067011 laut Crossref)

    Checked 26 Oct 2026 via PubMed, Crossref, doi.org
  3. Tretinoin in ChEMBL (mechanism, approval)

    ChEMBL, EMBL-EBI (CHEMBL38)

    Checked 26 Oct 2026 via ChEMBL

Poes

Tretinoin (Retin-A) in the catalog

Suurused, hinnad ja tarneajad on tootelehel.

Toote juurde